Press releases

Month Year

Email alerts

May 18, 2015

Data Show Medtronic Quadripolar CRT Technology Optimizes Treatment for Heart Failure Patients

Positive Results from Two Studies Featured at Heart Rhythm Society 36th Annual Scientific Sessions

DUBLIN and BOSTON - MAY 18, 2015 -Medtronic plc (NYSE: MDT) today announced study results demonstrating that its quadripolar cardiac resynchronization therapy (CRT) system gives physicians more...
May 12, 2015

Medtronic Receives FDA Approval and CE Mark for Arctic Front Advance® ST Cryoballoon to Treat Atrial Fibrillation

Third-Generation Cryoballoon Designed to Allow Enhanced Positioning and Help Improve Capture of Real-Time Data with Achieve® Mapping Catheter

DUBLIN - May 12, 2015 - Medtronic plc (NYSE: MDT) today announced the Arctic Front Advance® ST Cryoablation Catheter has received U.S. Food and Drug Administration (FDA) approval for the...
May 7, 2015

Medtronic Initiates Study Of ‘In-Office’ Insertion Of Reveal LINQ™ Cardiac Monitor

RIO 2 Study Evaluates Safety and Effectiveness of Moving the Insertion Procedure from Hospital to Office Setting

DUBLIN – May 7, 2015 – Medtronic plc (NYSE: MDT) today announced the first inoffice implant of its miniaturized cardiac monitor as part of the Medtronic Reveal LINQ In-Office 2 (RIO 2) Study....
Feb 19, 2015

Medicare Approves Transitional Pass-Through Payment for Outpatient Use of Medtronic Drug-Coated Balloon

CMS Decision Provides Supplemental Reimbursement to U.S. Hospitals for New Medical Device with Potential to Improve Standard of Care for Peripheral Arterial Disease in Upper Leg

DUBLIN - Feb. 19, 2015 - Medtronic plc (NYSE: MDT) announced today that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a transitional pass-through payment for the company's...
Feb 11, 2015

Medtronic Insertable Cardiac Monitors Detect Atrial Fibrillation In Stroke Patients In ‘Real – World’ Study

Findings Reinforce Patient Benefit of Reveal LINQ in Real-World Setting

DUBLIN and NASHVILLE – Feb. 11, 2015 – Medtronic plc (NYSE: MDT), today announced the results of a new “real-world” study of patients who have had a cryptogenic stroke (stroke of unknown...

Show per page